Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, S2Medical AB's Enterprise Value is kr3.96 Mil.
S2Medical AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was kr-0.54 Mil. Therefore, S2Medical AB's EV-to-EBIT ratio for today is -7.31.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, S2Medical AB's Enterprise Value is kr3.96 Mil.
S2Medical AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was kr0.09 Mil. Therefore, S2Medical AB's EV-to-EBITDA ratio for today is 42.62.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, S2Medical AB's Enterprise Value is kr3.96 Mil.
S2Medical AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was kr6.89 Mil. Therefore, S2Medical AB's EV-to-Revenue ratio for today is 0.58.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, S2Medical AB's Enterprise Value is kr3.96 Mil.
S2Medical AB's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was kr0.28 Mil. Therefore, S2Medical AB's EV-to-FCF ratio for today is 13.96.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
S2Medical AB (OSTO:S2M) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
S2Medical AB's current Enterprise Value is kr3.96 Mil.
S2Medical AB's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.54 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
S2Medical AB's current Enterprise Value is kr3.96 Mil.
S2Medical AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.09 Mil.
S2Medical AB's current Enterprise Value is kr3.96 Mil.
S2Medical AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr6.89 Mil.
S2Medical AB's current Enterprise Value is kr3.96 Mil.
S2Medical AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.29 Mil.
S2Medical AB's current Enterprise Value is kr3.96 Mil.
S2Medical AB's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.28 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
S2Medical AB Enterprise Value Related Terms
S2Medical AB Enterprise Value Historical Data
* Premium members only.
The historical data trend for S2Medical AB's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:S2M vs ISRG, BDX, MDLN: Enterprise Value Comparison
For the Medical Instruments & Supplies subindustry, S2Medical AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
S2Medical AB Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, S2Medical AB's Enterprise Value distribution charts can be found below:
* The bar in red indicates where S2Medical AB's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
S2Medical AB's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
S2Medical AB (OSTO:S2M) has a Enterprise Value of kr3.96 Mil as of Jul. 03, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on S2Medical AB and its competitors.
Is S2Medical AB's Enterprise Value too high?
S2Medical AB's current Enterprise Value is kr3.96 Mil.
How does S2Medical AB's Enterprise Value compare to ISRG and BDX?
S2Medical AB's Enterprise Value of kr3.96 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on S2Medical AB and its competitors. S2Medical AB's current Enterprise Value is kr3.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is S2Medical AB stock overvalued right now?
Based on GuruFocus' analysis, S2Medical AB (OSTO:S2M) is currently considered Possible Value Trap. The stock's GF Value™ is kr0.01, compared to a current price of kr0.01 — trading 48% below its estimated fair value. The current Enterprise Value is kr3.96 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For S2Medical AB (OSTO:S2M), the current Enterprise Value is kr3.96 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
S2Medical AB is a research-intensive MedTech company from Sweden. The company develops products within the entire wound healing process from debridement and granulation to re-epithelialization. products for the initial phase of a wound's healing process until the end, when the wound is completely healed. S2Medical also has in its portfolio the product NoSmell for odor removal which is procured in several different Swedish healthcare regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:S2M has been successfully added to your 